OCREVUS dosing and administration.

Learn how to treat RMS and PPMS patients using OCREVUS

OCREVUS is administered by IV infusion as a 600 mg dose every 6 months. Learn about the full dosing cycle, along with the requirements for infection assessment, pre-treatment evaluation, and pre-treatment medications.

Managing infusion-related reactions.

Understand more about IRRs

Learn how to manage infusion-related reactions (IRRs) in your OCREVUS patients.